Last reviewed · How we verify
Pelvic Inflammatory Disease
Approved treatments
- Zithromax · Pfizer Inc.
Azithromycin is a macrolide antibacterial drug.
Clinical guidelines
- FDA label — not specified
Azithromycin is not specifically indicated for pelvic inflammatory disease in the provided text. - FDA label — 1L
Ceftriaxone is indicated for the treatment of pelvic inflammatory disease caused by Neisseria gonorrhoeae. Ceftriaxone has no activity against Chlamydia trachomatis; therefore, appropriate antichlamydial coverage should be added when chlamydia is one of the suspected pathogens.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pelvic Inflammatory Disease patent landscape — cliff calendar, originator estates, attackable patents
- Pelvic Inflammatory Disease treatment landscape brief
- Pelvic Inflammatory Disease treatment updates RSS
Frequently asked questions about Pelvic Inflammatory Disease
What drugs treat Pelvic Inflammatory Disease?
Tracked treatments include Zithromax.
What is the treatment for Pelvic Inflammatory Disease?
Standard treatment for Pelvic Inflammatory Disease includes Zithromax. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Pelvic Inflammatory Disease?
FDA label publishes guidelines for Pelvic Inflammatory Disease. 2 guideline references tracked.
Related
- Treatment landscape: Pelvic Inflammatory Disease patent cliff · Pelvic Inflammatory Disease CI report
- Treatment: Zithromax · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing